Use Adult Dosing for This 16-Year-Old
For a 16-year-old weighing 220 pounds, you should administer the adult dose of Robitussin, not the children's dose. According to FDA labeling, patients 12 years and older receive the adult dose of 2-4 teaspoonfuls (10-20 mL) every 4 hours 1, 2.
Dosing Algorithm
The decision is straightforward and based on age, not weight:
- Age ≥12 years → Adult dose (2-4 teaspoonfuls every 4 hours)
- Age 6 to <12 years → Pediatric dose (1-2 teaspoonfuls every 4 hours)
- Age <6 years → Do not use 1
Your patient at 16 years old clearly falls into the adult dosing category.
Why Age Trumps Weight Here
While this patient's weight (220 lbs/100 kg) is above average, the FDA labeling for guaifenesin and dextromethorphan uses age-based dosing cutoffs rather than weight-based calculations 1, 2. This approach is standard for over-the-counter cough medications.
Research confirms that by age 12 and beyond, children have mature drug elimination pathways and differ from adults primarily in size, not metabolic capacity 3. Pharmacokinetic studies show that when comparing upper pediatric doses (ages 2-11) with lower adolescent doses (ages 12-17), similar systemic exposure occurs, supporting the age-based transition 4.
Critical Caveat About OTC Cough Medications
Before recommending any OTC cough medication, consider whether it's truly indicated. The 2020 CHEST guidelines explicitly state that OTC cough medications have minimal benefit for acute cough in children, and preparations containing dextromethorphan have been associated with adverse events 5. The guidelines recommend against prescribing OTC cough and cold medicines until proven to make cough less severe or resolve sooner 5.
For chronic cough, treat based on etiology, not symptoms 5. If this patient has asthma, treat the asthma. If bacterial infection, use antibiotics. Symptomatic cough suppression should not replace diagnosis-directed therapy.
Practical Considerations
- Maximum 6 doses in 24 hours 2
- The adult dose range (2-4 teaspoonfuls) allows titration based on symptom severity
- Monitor for adverse effects, which occurred most frequently at higher doses in pediatric studies 6
- Recent evidence shows dextromethorphan provides modest but statistically significant reductions in daytime cough frequency (25.5% vs placebo) in children ages 6-11 7, though nighttime effects were not demonstrated
The bottom line: At 16 years old, this patient receives adult dosing regardless of weight, but question whether OTC cough medication is the appropriate treatment at all.